3rd Quarter - Report

FIERCE, ISAKOWITZ & BLALOCK for GENERIC PHARMACEUTICAL ASSOCIATION

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S.369: Preserve Access to Affordable Generics Act

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 369 (111th)

Medicare/Medicaid MMM

H.R.3200: America's Affordable Health Choices Act of 2009 Americas Healthy Future Act S.1679: The Affordable Health Choices Act - Dual Eligibilities - Generic Free Refill - Biosimilar Reimbursement

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3200 (111th), S. 1679 (111th)

Budget/Appropriations BUD

Funding for the Office of Generic Drugs S.1406: Senate Agriculture Appropriations Bills FY 2010

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1406 (111th)

Health Issues HCR

S.726/H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548: Pathway for Biosimilars Act Comprehensive Health Reform H.R.3200: America's Affordable Health Choices Act of 2009 Americas Healthy Future Act S.1679: The Affordable Health Choices Act S.Res287: Honoring the 25th Anniversary of the Enactment of the Drug Price Competition and Patent Term Restoration Act of 1984 Americas Healthy Future Act of 2009 - Labeling Lawsuits

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Res. 287 (111th), S. 1679 (111th), S. 726 (111th), H.R. 1427 (111th), H.R. 3200 (111th), H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.